N-acetylglucopyranosylamine

structure given in first source

Also Known As:

1-GlcNAc; N-acetyl-beta-D-glucopyranosylamine

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

1.	Type 2 Diabetes Mellitus (MODY) 01/01/2003 - "Physiological investigations have been carried out with N-acetyl-beta-D-glucopyranosylamine 6, spiro-thiohydantoin 18, isofagomine 45, and DAB 56 to underline the potential use of these compounds in the treatment of type 2 diabetes. "